Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-014419
Filing Date
2017-08-10
Accepted
2017-08-10 16:13:09
Documents
77
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20170630_10q.htm 10-Q 1306252
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10486
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10906
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 4627
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 4221
  Complete submission text file 0001437749-17-014419.txt   7579443

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS nby-20170630.xml EX-101.INS 1773379
7 EXHIBIT 101.SCH nby-20170630.xsd EX-101.SCH 80353
8 EXHIBIT 101.CAL nby-20170630_cal.xml EX-101.CAL 36536
9 EXHIBIT 101.DEF nby-20170630_def.xml EX-101.DEF 503080
10 EXHIBIT 101.LAB nby-20170630_lab.xml EX-101.LAB 417123
11 EXHIBIT 101.PRE nby-20170630_pre.xml EX-101.PRE 524358
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 171021604
SIC: 2834 Pharmaceutical Preparations